Please login to the form below

Not currently logged in

NICE to speed up adoption of health technologies

National Institute for Health and Care Excellence NICE logo

Launches new Office for Market Access

Lilly drops evacetrapib on failed atherosclerosis trial

Leaves hole in company's late-stage pipeline

UK HCPs back transparency over their pharma payments

Survey comes as pharma companies prepare for payment disclosure database

Lilly acquires rights to intranasal glucagon spray

Eli Lilly HQCould be first needle-less emergency treatment for hypoglycaemia

AZ halts durvalumab combination trials on safety grounds

AstraZeneca AZ headquarters London UKSays move is a precautionary step after respiratory disease reports

BMS gets OK for broader Opdivo use in lung cancer

Bristol-Myers Squibb (BMS) buildingUS regulator's decision allows firm to edge in front of Merck & Co's Keytruda

Boehringer says anti-IL-23 drug beats Stelara in psoriasis trial

Boehringer Ingelheim headquartersInterleukin-23 inhibitor outperforms Johnson & Johnson's blockbuster

NICE recommends Keytruda for advanced skin cancer

National Institute for Health and Care Excellence NICE logoSecond recommendation for drug in a week

Neurocrine plans movement disorder drug filing in 2016

NBI-98854 in trials for tardive dyskinesia

A Schengen area of healthcare

Moving to a more coordinated and cooperative European response to health threats

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company

WE’s global and European healthcare hub is based in London, and works with experienced teams across the globe; teams encompassing...

Latest intelligence

White paper download: Healthy brand storytelling
Download our storytelling for pharma white paper to see how you can use stories to educate, inspire and truly connect with your audience....
Infographic: Spondyloarthritis
Overview of spondyloarthritis patient profiles and treatment pathways....
Webinar: Demand assessment - Reflecting real world choices
How study design which reflects doctors’ real world choices can optimise results....